The investment objective of Durlacher Growth Plus is to achieve long-term capital appreciation in excess of the FT All-Share Index.
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.9% |
Vodafone Group | 5.5% |
Reckitt Benckiser | 5.4% |
Wal-Mart Stores | 5.0% |
Pfizer | 4.7% |
Smith & Nephew | 4.3% |
Capita Group | 4.2% |
British Sky Broadcasting Group | 4.1% |
Compass Group ord 10p | 4.1% |
HBOS | 3.9% |
Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.9% |
Vodafone Group | 5.5% |
Reckitt Benckiser | 5.4% |
Wal-Mart Stores | 5.0% |
Other | 78.2% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 12/02/2002 |
---|---|
Fund Manager | Simon Steele |
TER | - |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | n/a |
Savings | 100 |
Charges | |
---|---|
Initial | 4.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.01 |
You are here: research